ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA clears Amgen’s Prolia for glucocorticoid osteoporosis
pharmatimes
May 24, 2018The decision allows physicians to prescribe the drug to patients with a history of osteoporotic fracture, those with multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.
Pharma Sources Insight January 2025
